Kirin leans into health products and drugs, pouring in $900m - Nikkei Asia
Kirin leans into health products and drugs, pouring in $900m Nikkei Asia
Healthcare, Pharmaceutical, Biotechnology, Clinical Research & MedTech Industry News
Kirin leans into health products and drugs, pouring in $900m Nikkei Asia
Chinese eye hospital to buy 35% stake in Singapore-listed peer Nikkei Asia
Health authorities order halt to use of medical devices tied to patient's death South China Morning Post